: Cell growth inhibition curves under normoxic and hypoxic conditions, by cell count.
Supplementary
: Anti-tumor effect of paclitaxel in MDA-MB-231 xenografts. Tumor weight was compared between drug regimens at each time point using a two-way ANOVA test (p < 0.001) followed by Bonferroni a posteriori test on logtransformed data. Color-filled symbols indicate significant (p < 0.01) differences between treated vs. vehicle mice. Dotted vertical lines indicate the treatment period (n = 8). Mice were subcutaneously injected in the right flank with 10 × 10 6 MDA-MB-231 cells and 12 days after randomized (eight animals/group) into vehicle (cremophor:ethanol 1:1 was used to dissolve paclitaxel, then diluted 1:5 with saline; once weekly, intravenous) or 0.15 mg/kg paclitaxel, once weekly, intravenous. Tumor weight and treatment efficacy were evaluated as described in the Material and Methods section. Tolerability was determined on the basis of body weight loss, clinical observation and mortality. Mice were sacrificed at the first sign of severe distress. 
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